Marc Schmalzing
Arzt,
Internist
Geboren:
1974
Hat mitgewirkt an:
-
Subgruppenspezifische Therapiestrategien bei rheumatisch-entzündlichen Erkrankungen
-
Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: an observational cohort study
-
Correction to: Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: an observational cohort study
-
Use of a “critical difference” statistical criterion improves the predictive utility of the Health Assessment Questionnaire-Disability Index score in patients with rheumatoid arthritis